Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis – a medicinal chemist perspective

Tuberculosis (TB), one of the most prevalent infections, is on the rise today. Although there are drugs available in the market to combat this lethal disorder, there are several shortcomings with the current drug regimen, such as prolonged treatment period, drug resistance, high cost, etc. Hence, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Suresh, Amaroju, Srinivasarao, Singireddi, Khetmalis, Yogesh Mahadu, Nizalapur, Shashidhar, Sankaranarayanan, Murugesan, Gowri Chandra Sekhar, Kondapalli Venkata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057165/
https://www.ncbi.nlm.nih.gov/pubmed/35521286
http://dx.doi.org/10.1039/d0ra07398a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057165/
https://www.ncbi.nlm.nih.gov/pubmed/35521286
http://dx.doi.org/10.1039/d0ra07398a

Ejemplares similares